Fig. 10.From: PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human studyTime-activity curves of [11C]MC1 uptake in representative body parts of patient 1 with rheumatoid arthritis under baseline and blocked conditions. Celecoxib (400 mg) was used as the blocking agentBack to article page